SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-064243
Filing Date
2024-05-22
Accepted
2024-05-22 16:03:29
Documents
13
Period of Report
2024-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2415277d1_8k.htm   iXBRL 8-K 36587
  Complete submission text file 0001104659-24-064243.txt   212332

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pasg-20240521.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20240521_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20240521_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2415277d1_8k_htm.xml XML 3826
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 24973197
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)